SEC INSIDER TRANSACTIONS

GENERAL ELECTRIC CO (GE) Insider Transactions

Explore official ownership filings, with every record linked to its source.

Reported data · not live

GE · GENERAL ELECTRIC CO

Filing window SEC codes (comma separated) Security type Order

More transaction filters

Roles: director,officer,ten_percent_owner,otherOwner nameOfficer titleOwnership: D, I, unknownoriginal or amendedTransaction fromTransaction throughFiled fromFiled throughMinimum quantityMaximum quantityMinimum priceMaximum priceMinimum calculated valueMaximum calculated valueResults per page (1–100)

OR within codes/roles; AND between categories. Roles apply to buyers and sellers. Owner predicates match the same owner. Missing values fail numeric/date filters. Value is quantity × reported price for non-derivative rows only; derivative values are unknown. Amendments stay separate; joint owners do not duplicate rows.

Reset filters

Active filters: days=6m

Stale snapshot · Covered: filings 2026-05-14 to 2026-11-13 · 12 filings · fetched 2026-11-13T17:58:20Z

Recent reported activity

0purchase rows on this page

12sale rows on this page

28matching filing rows

Purchases and sales count original non-derivative P and S rows. Awards, gifts, exercises, derivatives and amendments are shown separately and are not described as market purchases.

Transaction / filed	Reporting owner(s)	Code / security	Quantity	Price as filed	Ownership	Source
2026-11-11Filed 2026-11-12	CULP H LAWRENCE JRDirector · Officer · Chairman and CEO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The reported sale of shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 12, 2026. F2 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $338.64 to $337.89, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $337.85 to $336.88, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. References: F1, F3	S Sale (market/private)Common Stock · Non-derivative	7,321D	337.25	IndirectBy family trusts	Form 4 ↗0001205247-26-000010
2026-11-11Filed 2026-11-12	CULP H LAWRENCE JRDirector · Officer · Chairman and CEO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The reported sale of shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 12, 2026. F2 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $338.64 to $337.89, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $337.85 to $336.88, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. References: F1, F2	S Sale (market/private)Common Stock · Non-derivative	679D	338.29	IndirectBy family trusts	Form 4 ↗0001205247-26-000010
2026-11-04Filed 2026-11-05	Giglietti Robert M.Officer · Vice President Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Exercise of Employee Stock Options expiring in March 2029. F2 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $331.56 to $332.45, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 The Employee Stock Options in this grant are fully vested. References: F3	M Exercise / conversionEmployee Stock Option (right to buy) · Derivative	14,796D	0	Direct	Form 4 ↗0001953063-26-000011
2026-11-04Filed 2026-11-05	Giglietti Robert M.Officer · Vice President Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Exercise of Employee Stock Options expiring in March 2029. F2 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $331.56 to $332.45, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 The Employee Stock Options in this grant are fully vested. References:	S Sale (market/private)Common Stock · Non-derivative	11,016D	332.69	Direct	Form 4 ↗0001953063-26-000011
2026-11-04Filed 2026-11-05	Giglietti Robert M.Officer · Vice President Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Exercise of Employee Stock Options expiring in March 2029. F2 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $331.56 to $332.45, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 The Employee Stock Options in this grant are fully vested. References: F2	S Sale (market/private)Common Stock · Non-derivative	3,780D	332.12	Direct	Form 4 ↗0001953063-26-000011
2026-11-04Filed 2026-11-05	Giglietti Robert M.Officer · Vice President Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Exercise of Employee Stock Options expiring in March 2029. F2 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $331.56 to $332.45, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 The Employee Stock Options in this grant are fully vested. References: F1	M Exercise / conversionCommon Stock · Non-derivative	14,796A	52.38	Direct	Form 4 ↗0001953063-26-000011
2026-09-30Filed 2026-10-02	Althoff JudsonDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Acquired at a price of $321.80 per unit pursuant to the terms of the GE Aerospace 2024 Non-Employee Director Compensation Plan. F2 Each unit of phantom stock is the economic equivalent of one share of the issuer's common stock. F3 Payable beginning one year after termination of service as a director. References: F1, F2, F3	A Award / grantPhantom Stock Units · Derivative	35A	321.8	Direct	Form 4 ↗0001868758-26-000013
2026-09-30Filed 2026-10-02	Bazin SebastienDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Acquired at a price of $321.80 per unit pursuant to the terms of the GE Aerospace 2024 Non-Employee Director Compensation Plan. F2 Each Phantom Stock Unit is the economic equivalent of one share of the issuer's common stock. F3 Payable beginning one year after termination of service as a director. References: F1, F2, F3	A Award / grantPhantom Stock Units · Derivative	117A	321.8	Direct	Form 4 ↗0001671730-26-000007
2026-09-30Filed 2026-10-02	BUSH WESLEY GDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Acquired at a price of $321.80 per unit pursuant to the terms of the GE Aerospace 2024 Non-Employee Director Compensation Plan. F2 Each Phantom Stock Unit is the economic equivalent of one share of the issuer's common stock. F3 Payable beginning one year after termination of service as a director. References: F1, F2, F3	A Award / grantPhantom Stock Units · Derivative	120A	321.8	Direct	Form 4 ↗0001216503-26-000009
2026-08-11Filed 2026-08-12	Giglietti Robert M.Officer · Vice President Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Exercise of Employee Stock Options expiring in December 2028. F2 The Employee Stock Options in this grant are fully vested. References: F2	M Exercise / conversionEmployee Stock Option (right to buy) · Derivative	10,242D	0	Direct	Form 4 ↗0001953063-26-000009
2026-08-11Filed 2026-08-12	Giglietti Robert M.Officer · Vice President Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Exercise of Employee Stock Options expiring in December 2028. F2 The Employee Stock Options in this grant are fully vested. References:	S Sale (market/private)Common Stock · Non-derivative	4,898D	369.97	Direct	Form 4 ↗0001953063-26-000009
2026-08-11Filed 2026-08-12	Giglietti Robert M.Officer · Vice President Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Exercise of Employee Stock Options expiring in December 2028. F2 The Employee Stock Options in this grant are fully vested. References:	S Sale (market/private)Common Stock · Non-derivative	5,344D	369.88	Direct	Form 4 ↗0001953063-26-000009
2026-08-11Filed 2026-08-12	Giglietti Robert M.Officer · Vice President Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Exercise of Employee Stock Options expiring in December 2028. F2 The Employee Stock Options in this grant are fully vested. References: F1	M Exercise / conversionCommon Stock · Non-derivative	10,242A	36.65	Direct	Form 4 ↗0001953063-26-000009
2026-07-24Filed 2026-07-28	Ali MohamedOfficer · Senior Vice President Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Exercise of Employee Stock Options expiring in November 2027. F2 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $353.72 to $353.74, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 Exercise of Employee Stock Options expiring in March 2028. F4 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $353.63 to $353.73, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F5 The Employee Stock Options in this grant are fully vested. References: F5	M Exercise / conversionEmployee Stock Option (right to buy) · Derivative	5,061D	0	Direct	Form 4 ↗0002052951-26-000007
2026-07-24Filed 2026-07-28	Ali MohamedOfficer · Senior Vice President Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Exercise of Employee Stock Options expiring in November 2027. F2 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $353.72 to $353.74, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 Exercise of Employee Stock Options expiring in March 2028. F4 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $353.63 to $353.73, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F5 The Employee Stock Options in this grant are fully vested. References: F5	M Exercise / conversionEmployee Stock Option (right to buy) · Derivative	3,035D	0	Direct	Form 4 ↗0002052951-26-000007
2026-07-24Filed 2026-07-28	Ali MohamedOfficer · Senior Vice President Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Exercise of Employee Stock Options expiring in November 2027. F2 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $353.72 to $353.74, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 Exercise of Employee Stock Options expiring in March 2028. F4 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $353.63 to $353.73, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F5 The Employee Stock Options in this grant are fully vested. References: F4	S Sale (market/private)Common Stock · Non-derivative	2,279D	353.64	Direct	Form 4 ↗0002052951-26-000007
2026-07-24Filed 2026-07-28	Ali MohamedOfficer · Senior Vice President Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Exercise of Employee Stock Options expiring in November 2027. F2 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $353.72 to $353.74, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 Exercise of Employee Stock Options expiring in March 2028. F4 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $353.63 to $353.73, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F5 The Employee Stock Options in this grant are fully vested. References:	S Sale (market/private)Common Stock · Non-derivative	2,782D	353.72	Direct	Form 4 ↗0002052951-26-000007
2026-07-24Filed 2026-07-28	Ali MohamedOfficer · Senior Vice President Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Exercise of Employee Stock Options expiring in November 2027. F2 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $353.72 to $353.74, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 Exercise of Employee Stock Options expiring in March 2028. F4 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $353.63 to $353.73, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F5 The Employee Stock Options in this grant are fully vested. References: F3	M Exercise / conversionCommon Stock · Non-derivative	5,061A	69.55	Direct	Form 4 ↗0002052951-26-000007
2026-07-24Filed 2026-07-28	Ali MohamedOfficer · Senior Vice President Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Exercise of Employee Stock Options expiring in November 2027. F2 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $353.72 to $353.74, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 Exercise of Employee Stock Options expiring in March 2028. F4 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $353.63 to $353.73, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F5 The Employee Stock Options in this grant are fully vested. References: F2	S Sale (market/private)Common Stock · Non-derivative	1,266D	353.74	Direct	Form 4 ↗0002052951-26-000007
2026-07-24Filed 2026-07-28	Ali MohamedOfficer · Senior Vice President Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Exercise of Employee Stock Options expiring in November 2027. F2 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $353.72 to $353.74, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 Exercise of Employee Stock Options expiring in March 2028. F4 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $353.63 to $353.73, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F5 The Employee Stock Options in this grant are fully vested. References:	S Sale (market/private)Common Stock · Non-derivative	1,769D	353.75	Direct	Form 4 ↗0002052951-26-000007
2026-07-24Filed 2026-07-28	Ali MohamedOfficer · Senior Vice President Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Exercise of Employee Stock Options expiring in November 2027. F2 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $353.72 to $353.74, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 Exercise of Employee Stock Options expiring in March 2028. F4 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $353.63 to $353.73, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F5 The Employee Stock Options in this grant are fully vested. References: F1	M Exercise / conversionCommon Stock · Non-derivative	3,035A	90.01	Direct	Form 4 ↗0002052951-26-000007
2026-07-23Filed 2026-07-27	Procacci RiccardoOfficer · Senior Vice President Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Exercise of Employee Stock Options expiring in September 2026. F2 The Employee Stock Options in this grant are fully vested. References: F2	M Exercise / conversionEmployee Stock Option (right to buy) · Derivative	1,517D	0	Direct	Form 4 ↗0002015929-26-000007
2026-07-23Filed 2026-07-27	Procacci RiccardoOfficer · Senior Vice President Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Exercise of Employee Stock Options expiring in September 2026. F2 The Employee Stock Options in this grant are fully vested. References:	S Sale (market/private)Common Stock · Non-derivative	491D	347.9	Direct	Form 4 ↗0002015929-26-000007
2026-07-23Filed 2026-07-27	Procacci RiccardoOfficer · Senior Vice President Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Exercise of Employee Stock Options expiring in September 2026. F2 The Employee Stock Options in this grant are fully vested. References:	S Sale (market/private)Common Stock · Non-derivative	1,026D	347.93	Direct	Form 4 ↗0002015929-26-000007
2026-07-23Filed 2026-07-27	Procacci RiccardoOfficer · Senior Vice President Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Exercise of Employee Stock Options expiring in September 2026. F2 The Employee Stock Options in this grant are fully vested. References: F1	M Exercise / conversionCommon Stock · Non-derivative	1,517A	146.33	Direct	Form 4 ↗0002015929-26-000007

Imported instruments only. Joint owners do not multiply transactions. Amendments are separate filing rows, not additional trades. No aggregate trade totals are implied.